|
Media, News, Press Release
【Successful Development of Pathological AI】Now Possible to Classify Prostate Cancer in Histopathological Whole Slide Images -Published in Diagnostics-
Medmain Inc., a provider of the digital pathology support solutions “PidPort”, has successfully developed a pathological AI that enables to classify prostate cancer with extremely high accuracy in needle biopsy whole slide images using transfer learning.
We are also pleased to announce that a paper on this development has been posted on Diagnostics, issued by MDPI (https://www.mdpi.com), and was published in a special issue of Artificial Intelligence in Pathological Image Analysis on March 21, 2022.
